Sagimet Biosciences Raises $107.5 Million in Underwritten Offering

Sagimet Biosciences has secured $107.5 million through an underwritten offering of common stock and pre-funded warrants. The offering involves 8,750,010 shares of common stock at $10.00 per share and 2,750,010 pre-funded warrants at $9.9999 per warrant. The transaction is anticipated to close on October 1, 2026.